Skip to main content

Table 6 Prevalence of glucose homeostasis abnormalities according to body composition categorised into 4 groups of fat distribution

From: Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance

Categories of fat distribution by clinical lipoatrophy and WC Categories of fat distribution by FMR and WC
  CLA- AP- CLA-AP+ CLA + AP- CLA + AP+ P L- AP- L-AP+ L + AP- L + AP+ P
NG [n (%)] 17 (56.7) 27 (45.8) 41 (58.6) 22 (37.3) 0.064 39 (61.9) 32 (50.8) 19 (51.4) 17 (30.9) 0.002
IFG [n (%)] 1 (3.3) 9 (15.3) 4 (5.7) 4 (6.8)   0 (0.0) 7 (11.1) 5 (13.5) 6 (10.9)  
IGT [n (%)] 5 (16.7) 16 (27.1) 10 (14.3) 18 (30.5)   9 (14.3) 17 (27.0) 6 (16.2) 17 (30.9)  
DM [n (%)] 7 (23.3) 7 (11.9) 15 (21.4) 15 (25.4)   15 (23.8) 7 (11.1) 7 (18.9) 15 (27.3)  
  1. (NG- normal glucose; IFG – impaired fasting glucose: IGT – impaired glucose tolerance; DM – diabetes mellitus; CLA – Clinical lipoatrophy; AP – abdominal prominence defined by waist circumference >80 cm in women and >94 cm in men – IDF 2005; L- lipodystrophy FMR defined; CLA-AP-: no lipodystrophy; CLA-AP+: isolated central fat accumulation; CLA + AP-: isolated lipoatrophy; CLA + AP+: mixed forms of lipodystrophy).